Sunday, January 29, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Crowdsourcing a Virtual Supercomputer to Fight Disease

by Global Biodefense Staff
March 25, 2016
DoD Seeks Tuberculosis Disinfectant

Tuberculosis MycobacteriumIBM’s World Community Grid and scientists at the University of Nottingham are launching a study to address tuberculosis, one of the world’s deadliest diseases. It is expected that hundreds of thousands of volunteers will donate vast computing resources to aid this effort facilitated by IBM.

The new “Help Stop TB” project on IBM World Community Grid will model aspects of the behavior of tuberculosis bacteria to better understand its potential vulnerabilities that new medicines may one day exploit.

Volunteers will make the processing power on their devices available, when otherwise not being used, to perform the millions of calculations necessary for these simulations. Crowdsourcing a virtual supercomputer in this manner to study the disease will provide results significantly faster and achieve greater results than relying on conventional computational resources typically available to researchers.

Tuberculosis (TB) has plagued humans for thousands of years. Approximately one third of the globe’s human population harbors TB today and 1.5 million people died from it in 2014, prompting the World Health Organization to rank TB alongside HIV as the world’s deadliest infectious disease.

“TB is one of the world deadliest infectious diseases, along with HIV, and one third of the world’s population harbors the TB bacterium. My team will use World Community Grid to help science better understand the TB bacterium, so we can develop more effective treatments, and eventually eradicate this threat to human health,” commented Dr. Anna Croft, lead researcher of the Help Stop TB project and Associate Professor, Faculty of Engineering at the University of Nottingham in the UK.

Although several drugs and a partially effective vaccine have been developed to help combat TB, the TB bacterium can evolve to resist available medicine, particularly when patients interrupt or discontinue treatment, which often occurs when they do not have consistent access to medications and medical care. Nearly half of European cases are now resistant to at least one drug, and 4% of all cases worldwide are resistant to treatment regimens that combine drugs. HIV patients with weakened immune systems are especially vulnerable to TB.

The tuberculosis bacterium has a coating which shields it from many drugs and the patient’s immune system. Among the fats, sugars and proteins in this coat are fatty molecules called mycolic acids. The Help Stop TB project will use the computing power donated by World Community Grid members to simulate the behavior and chemical properties of mycolic acids to better understand how they protect the TB bacteria. Scientists hope to use the results to eventually develop better treatments for this deadly disease, particularly those that evade TB cell wall defenses.

World Community Grid was created in 2004 by IBM as part of its citizenship program focused on innovation. Hosted on IBM’s SoftLayer cloud technology, World Community Grid facilitates massive amounts of completely free computing power for scientists by harnessing the surplus cycle time of volunteers’ computers and Android devices from all over the globe. The combined power available on World Community Grid has created one of the most powerful and fastest virtual supercomputers on the planet.

“Thanks to World Community Grid’s massive computational power, we can study many different mycolic acid structures instead of just a few,” says Dr. Croft. “This type of analysis at this scale would otherwise be impossible.”

More than three million computers and mobile devices used by nearly three quarters of one million people globally and 470 institutions from 80 countries have contributed virtual supercomputing power that have fueled more than two-dozens vitally important projects on World Community Grid over the last 11 years.

Since the program’s inception, World Community Grid has enabled important scientific advances in areas such as cancer research, AIDS treatments, genetic mapping, solar energy and ecosystem preservation. Many of these efforts might not have even been attempted without the free supercomputing power provided by IBM’s World Community Grid.

World Community Grid is enabled by Berkeley Open Infrastructure for Network Computing (BOINC), an open source platform developed at the University of California, Berkeley and with support from the National Science Foundation.

Tags: Tuberculosis

Related Posts

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions
Pathogens

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Liverpool Synthetic Biology Lab Backed By 2M Award
Policy + Initiatives

Political Interference: White House Launches Framework to Protect Scientific Integrity

January 13, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
The device appears smaller than a playing card, transparent, with visible channels branching off.
Medical Countermeasures

How Organ-on-a-chip Models Could Grease the Drug Development Pipeline

January 10, 2023
Load More

Latest News

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023
Biodefense Headlines – 17 January 2023

Biodefense Headlines – 17 January 2023

January 17, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC